Latest Breaking News On - Alterity therapeutics limited - Page 1 : comparemela.com

Short Interest in Alterity Therapeutics Limited (NASDAQ:ATHE) Declines By 59 3%

Short Interest in Alterity Therapeutics Limited (NASDAQ:ATHE) Declines By 59 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Alterity therapeutics company profileAlterity therapeuticsAlterity therapeutics limitedGet free reportTherapeutics limitedAlterity therapeutics daily

Alterity Therapeutics to Present New Data on ATH434 at the

MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”),.

United statesSan franciscoRemy bernardaDanielo claassenMargaret bradburyDavid stamlerDaniel claassenHannah howlettDepartment of pharmaceutical sciencesNonclinical developmentEuropean commissionAlterity therapeuticsWorld orphan drug congress united statesAmerican academy of neurologyWayne state universityNational institute of health

Alterity Therapeutics Limited (NASDAQ:ATHE) Short Interest Up 47 5% in March

Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 26,400 shares, a growth of 47.5% from the February 29th total of 17,900 shares. Based on an average daily trading volume, of 41,500 […]

Alterity therapeuticsVirtu financialAlterity therapeutics limitedGet free reportFree reportTherapeutics limitedAlterity therapeutics dailyNasdaq athe

Alterity Therapeutics : Receives a $3 9 million Research & Development Tax Incentive Refund -March 25, 2024 at 11:28 pm EDT

Alterity Therapeutics Receives a $3.9 million Research & Development Tax Incentive Refund March 26, 2024March 26, 2024 Alterity Therapeutics .

United statesSan franciscoDavid stamlerDevelopment tax incentiveAustralian government researchAlterity therapeutics limitedAustralian taxation officeAlterity therapeuticsEuropean commissionTherapeutics limitedAustralian governmentMultiple system atrophyAbout alterity therapeutics limitedMultiple system

Alterity Therapeutics (ATHE) Receives a A$3 9 Million Research & Development Tax Incentive Refund

Alterity Therapeutics (ATHE) Receives a A$3 9 Million Research & Development Tax Incentive Refund
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alterity therapeutics limitedAustralian taxation officeDevelopment tax incentiveAustralian government researchAustralian government